Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-24

Clinical Trial Update: A Study of Sabroxy™ (Oroxylum Indicum Extract) for Improving Cognitive Function in Adults With Mild Memory Concerns [NA]

View source ↗

Summary

This clinical trial update reports a completed study of Sabroxy (Oroxylum indicum extract) aimed at improving cognitive function in adults with mild memory conc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sabroxy (Oroxylum indicum extract)

Snippet

Sponsor: SF Research Institute, Inc. | Conditions: Mild Cognitive Impairment (MCI), Cognitive Dysfunction, Cognitive Disorder | NA | Status: COMPLETED